These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 8889279
1. Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation. Cox KL, Freese DK. Clin Invest Med; 1996 Oct; 19(5):389-92. PubMed ID: 8889279 [Abstract] [Full Text] [Related]
2. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients. Ogino S, Hashikura Y, Katsuyama Y, Ikegami T, Nakazawa Y, Urata K, Terada M, Miyagawa S, Kawasaki S. Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357 [Abstract] [Full Text] [Related]
3. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R. Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [Abstract] [Full Text] [Related]
4. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants. Hedayat S, Kershner RP, Su G. J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977 [Abstract] [Full Text] [Related]
5. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M. J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [Abstract] [Full Text] [Related]
6. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J. Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [Abstract] [Full Text] [Related]
7. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Fan Y, Xiao YB, Weng YG. Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736 [Abstract] [Full Text] [Related]
16. Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens. Shiboski CH, Krishnan S, Besten PD, Golinveaux M, Kawada P, Tornabene A, Rosenthal P, Mathias R. Pediatr Dent; 2009 Jun; 31(1):38-46. PubMed ID: 19320258 [Abstract] [Full Text] [Related]
17. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH. Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753 [Abstract] [Full Text] [Related]
19. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. Ye F, Ying-Bin X, Yu-Guo W, Hetzer R. J Heart Lung Transplant; 2009 Jan; 28(1):58-66. PubMed ID: 19134532 [Abstract] [Full Text] [Related]
20. Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes. Walker RG, Cottrell S, Sharp K, Tripodi R, Nicholls KM, Fraser I, Varigos GA, Butcher BE. Nephrology (Carlton); 2007 Dec; 12(6):607-14. PubMed ID: 17995589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]